RT1(9a) Kit+Sca1−/lowCD34− AML cells exhibited variable combinations of FcgR, CD48, and CD14 (Fig. 4C), suggesting that leukemias may have developed from different subclones within that compartment. Here, CD48 is linked to acute myeloid leukemia.